Document is current
Any future updates will be listed below
-
Authors
Brouwer, Thomas P https://orcid.org/0000-0001-9947-6727
de Vries, Natasja L https://orcid.org/0000-0003-4966-7036
Abdelaal, Tamim
Krog, Ricki T
Li, Zheng
Ruano, Dina
Fariña, Arantza
Lelieveldt, Boudewijn P F
Morreau, Hans
Bonsing, Bert A
Vahrmeijer, Alexander L
Koning, Frits
de Miranda, Noel F C C https://orcid.org/0000-0001-6122-1024
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03829501 at ClinicalTrials.govDocuments that mention this clinical trial
Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry
https://doi.org/10.1136/jitc-2022-004638
T-cell agonists in cancer immunotherapy
https://doi.org/10.1136/jitc-2020-000966
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
https://doi.org/10.1136/esmoopen-2019-000544
Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies
https://doi.org/10.1136/jitc-2021-002591
-
Funding
Funding for this research was provided by:
European Union (852832)
MSCA (675743)
- License Information
